Glioblastoma Clinical Trials

Delta Trials records 775 clinical trials for Glioblastoma in its publicly accessible dataset. From the full dataset, 149 actively seeking eligible participants and 324 trials have reached completion. This research is conducted across 1,388 study locations around the world. An additional 302 trials are active but not currently open for enrollment. Since 2020, 104 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.